Major histocompatibility complex class I heavy chain (MHC class I heavy chain)

The Major histocompatibility complex class I heavy chain (MHC class I heavy chain) is the polymorphic alpha chain component of MHC class I molecules, forming a heterodimer with beta-2-microglobulin to present short peptides (8-10 amino acids) derived from cytosolic proteins on the surface of nearly all nucleated cells. This presentation enables CD8+ cytotoxic T cells to recognize and eliminate virus-infected cells, tumor cells, or other abnormal cells by inducing apoptosis, playing a central role in adaptive immunity against intracellular pathogens. The heavy chain features three domains: alpha1 and alpha2 form the closed-end peptide-binding groove, while alpha3 interacts with T cell receptors and beta-2-microglobulin stabilizes the complex. In disease, MHC class I heavy chain downregulation allows tumors and viruses to evade T cell detection, contributing to cancer progression and persistent infections, while polymorphisms influence transplant compatibility and autoimmune risks. Therapeutically, it is leveraged in cancer immunotherapies like checkpoint inhibitors, where restored presentation enhances T cell killing, though challenges include high polymorphism limiting universal targeting and potential for excessive immune activation.

Other names

MHC class I alpha chainHLA class I heavy chainMHC class I alpha heavy chain

Peptide loading and presentation to CD8+ T cells, Activation of cytotoxic responses against intracellular pathogens or tumors